The global sepsis diagnostics market is poised for significant growth, with an anticipated CAGR of 8.1% from 2023 to 2033. The market, valued at US$ 561.2 million in 2023, is projected to surpass US$ 1.2 billion by 2033.
Market Growth Drivers
Several key factors are driving the expansion of the sepsis diagnostics market:
- Rising Influenza Cases: An increasing number of individuals affected by the flu has contributed to heightened sepsis risks, driving demand for timely diagnostics.
- Hospital-Acquired Infections (HAIs): The prevalence of HAIs, which can progress to sepsis, emphasizes the need for advanced diagnostic tools in healthcare facilities.
- Aging Population: A growing geriatric population with chronic conditions such as diabetes and cardiovascular diseases increases vulnerability to sepsis, further propelling market growth.
Access the Full Report – https://www.futuremarketinsights.com/reports/sepsis-diagnostics-market
Market Opportunities and Challenges
- Advances in Technology: Innovations in diagnostic technologies, such as molecular diagnostics and biomarkers, are enhancing the accuracy and speed of sepsis detection.
- Global Healthcare Awareness: Increased focus on reducing sepsis-related mortality rates is expected to boost investments in sepsis diagnostics.
- Challenges: High costs of advanced diagnostic tools and limited access to healthcare in developing regions may restrict market penetration.
Regional Insights
- North America: Dominates the market due to robust healthcare infrastructure and a higher prevalence of HAIs.
- Asia-Pacific: Expected to register rapid growth, driven by increasing healthcare investments and rising awareness about sepsis management.
Market Forecast Highlights
- Market valuation is expected to grow from US$ 561.2 million in 2023 to over US$ 1.2 billion by 2033.
- The demand for rapid diagnostics is likely to surge as healthcare providers prioritize early sepsis detection to improve outcomes.
Manufacturers Carve a Niche by focusing on Innovation
The key players operating in the market focus on developing products, which are a blend of innovation and reliance. In August 2022, Biomerieux announced that its SPECIFIC REVEAL Rapid AST Systems received the Breakthrough Device Resignation from the United States Food and Drug Administration. The designation is deserved for medical devices that offer significant advantages over existing cleared alternatives.
Key developments in the market are:
- In July 2022, Biomerieux received Food and Drug Administration clearance for the NEPHROCHECK test on VIDAS.
- In August 2022, T2 BIOSYSTEMS announced that it would explore the potential to develop a rapid molecular diagnostic test for the monkeypox virus.
Sepsis Diagnostics Market Segmentation
By Product Type:
- Blood Culture Media
- Instrument
- Assays and Reagents
By Method:
- Conventional Diagnostics
- Automated Diagnostics
By Pathogen:
- Gram-negative Bacterial Sepsis
- Gram-positive Bacterial Sepsis
- Fungal Sepsis
- Other Pathogens
By Technology:
- Microbiology
- Molecular Diagnostics
- Immunoassays
- Other Technology
By Region:
- North America
- Latin America
- Europe
- Asia Pacific excluding Japan
- Japan
- The Middle East and Africa
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
COPD Therapeutics Market
Combat Dressing Market
Air Fluidized Therapy Beds Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube